Delivery Order SPE2DB20D2001-SPE2DB25FPNCD
- Not listed
- The Defense Logistics Agency awarded a $1,437.63 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lisdexamfetamine 10 mg capsules (90-count units). This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves no set-aside designation and was competitively awarded. Performance will occur...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units) under a firm fixed-price contract valued at $2,646.20. The contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,768.95 for 90 capsules of Lisdexamfetamine 60 mg on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lisdexamfetamine 10 mg capsules (100-count units) with a ceiling value of $1,278.13. This competitively awarded, firm fixed-price delivery order is set to be completed by July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Lisdexamfetamine 40 mg capsules in quantities of 100 units. This is a firm fixed price delivery order with a ceiling value of $1,480.44 and an ultimate completion date of August 7, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp will perform this work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100 count) with a ceiling value of $1,009.16. This competitive, firm fixed-price delivery order is scheduled for completion by May 14, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100-count units) with a ceiling value of $1,651.64. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be performed at AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (100 count) valued at $10,977.83. The contract, awarded on September 4, 2025, with an ultimate completion date of September 5, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will be conducted from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Lisdexamfetamine 60 mg capsules (100-count units) with a contract value of $1,525.84. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. As a child...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,883.72 for Lisdexamfetamine 30 mg capsules (100-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under the company's broader pharmaceutical supply arrangements with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNCDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,297.07 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 60 mg capsules (100-count units) on July 9, 2025, with completion targeted for July 10, 2025. The contract employs firm fixed pricing and was awarded without a set-aside designation, indicating open competition. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that functions as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive federal contract portfolio encompasses a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for Lisdexamfetamine—a central nervous system stimulant commonly prescribed for attention deficit hyperactivity disorder—exemplifies the company's role in fulfilling specialized pharmaceutical requirements for defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/9/25 |